|
Opening Plenary: Types of Evidence
Chair: Steven K. Clinton, MD, PhD, The Ohio State University Chair: Susan T. Mayne, PhD, Yale University and Yale Cancer Center Introduction: Steven Clinton, MD, PhD, and Susan Mayne, PhD
|
Presentation titles with this icon have related pdf files for download.
|
Diet and cancer: the role of observational studies Ed Giovannucci, MD, ScD, Harvard School of Public Health |
Diet and cancer: the role of clinical trials JoAnn Manson, MD, DrPH, Harvard Medical School |
Diet and cancer prevention: lessons from animal models and transdisciplinary studies Stephen Hursting, PhD, MPH, University of Texas at Austin |
|
Split Session A: Emerging Topics in Diet and Cancer Research
Chair: Robert S. Chapkin, PhD, Texas A&M University Chair: Stephen D. Hursting, PhD, MPH, University of Texas at Austin
|
Molecular mechanisms and chemoprotective properties of n-3 fatty acids: new insights Robert Chapkin, PhD, Texas A&M |
Clinical and translational studies of the anti-colorectal cancer activity of the n-3 polyunsaturated fatty acid eicosapentaenoic acid Mark Hull, PhD, FRCP, University of Leeds |
New insights into mechanisms of calorie restriction mediated inhibition of carcinogenesis: identifying targets for cancer prevention John DiGiovanni, PhD, University of Texas at Austin |
New technologies and analytic techniques for dietary assessment Amy Subar, PhD, MPH, RD, National Cancer Institute |
|
Split Session B: Cancer Treatment and Survivorship
Chair: Cheryl L. Rock, PhD, RD, University of California, San Diego
Chair: John A. Milner, PhD, National Cancer Institute
|
The impact of nutrition intervention in cancer cachexia Carla Prado, PhD, National Institutes of Health |
Micronutrient status and the nervous system in cancer: a balance between feeding the host and starving the tumor Ralph Green, MD, PhD, FRCPath, University of California, Davis |
Soy intake for the breast cancer survivor: evidence from the epidemiological literature Bette Caan, DrPH, Kaiser Permanente Division of Research |
Biological factors involved in mediating the effects of soy foods on breast cancer survivors Leena Hilakivi-Clarke, PhD, Georgetown University |
|
Friday, November 4
|
|
Breakfast Session
The WCRF/AICR Continuous Update Project: Keeping the evidence on food, nutrition, physical activity, and cancer up to date
Background and Methods Martin Wiseman, FRCP, FRCPath, World Cancer Research Fund International
Results So Far Rachel Thompson, PhD
|
|
Split Session C: Cancer Stem Cells
Chair: Young S. Kim, PhD, National Cancer Institute Chair: John A. Milner, PhD, National Cancer Institute
|
Normal stem cells vs. cancer stem cells: an overview Max Wicha, MD, University of Michigan |
Control of stem cells by diet and systemic factors in the Drosophila ovary Daniela Drummond-Barbosa, PhD, Johns Hopkins University |
The prostate stem cell as a target for prevention and treatment: vitamin D induced differentiation Scott Cramer, PhD, University of Colorado, Denver |
Dietary agents and stem cell survival proteins in skin cancer Richard Eckert, PhD, University of Maryland |
Targeting intestinal stem cells with dietary components Shrikant Anant, PhD, The University of Kansas |
|
Split Session D: Sedentary Behavior and Physical Activity
Chair: Christine Friedenreich, PhD, Alberta Health Services-Cancer Care Chair: June Stevens, MS, PhD, University of North Carolina at Chapel Hill
|
Observational and experimental evidence for the role of physical activity in cancer risk Christine Friedenreich, PhD, Alberta Health Services-Cancer Care |
Exercise rehabilitation following a cancer diagnosis: cardiorespiratory fitness to prognosis outcomes Lee W. Jones, PhD, Duke University |
Sedentary behavior: definitions and distinctions for cancer-prevention research Neville Owen, PhD, Baker IDI Heart and Diabetes Institute |
Sedentary behaviors and cancer: possible risks and biological mechanisms Charles E. Matthews, PhD, National Cancer Institute |
|
Closing Plenary: Vitamin D and Cancer
Chair: Steven K. Clinton, MD, PhD, The Ohio State University Chair: Susan T. Mayne, PhD, Yale University and Yale Cancer Center
|
Vitamin D and cancer – an overview Susan Mayne, PhD, Yale University |
Vitamin D and cancer – how strong is the evidence from observational studies? Demetrius Albanes, MD, National Cancer Institute |
Cellular and molecular actions of vitamin D in cancer Glenville Jones, PhD, Queen's University |
Using animal models to extend our understanding of the role vitamin D plays in cancer prevention James Fleet, PhD, Purdue University |
Vitamin D and cancer – summary and panel discussion Steven Clinton, MD, PhD, The Ohio State University |